Page 462 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C4.1. Descriptive characteristics of the randomized controlled trials and comparative cohort studies considered
relevant to KQ4 (continued)
Author, Year Study name Comparison Study Sample Inclusion criteria Population description: Quality
[Pubmed ID] /Database duration size (total) Age Comments
PSA (ng/mL)
Study design Tumor grade
Stage
Schymura 230 CDC-NPCR WW vs. RP 5 yr 3328 Histologically confirmed prostate Age: Under 70 yr, 57% B
2010 POCS vs. RT adenocarcinomas, localized
20403178 stage (clinically inapparent PSA: NR
tumor, or cT1c/cT2, N0/x, M0/x;
Retrospective or pT1/pT2 N0/x M0/x) Tumor grade: NR
cohort
T1 or T2: 100%

C-149